Healthy Volunteers Clinical Trial
— R-FORM'Official title:
Effect of a Health Check-up Followed by a Collective Coaching on the Quality of Life and Behavioral Change of Retired Persons. A Prospective Study Conducted in Ambulatory.
Verified date | May 2024 |
Source | Institut Pasteur de Lille |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Researchers have found that the first phase of aging, called "frailty", is insidious, silent and slowly progressive. It begins well before the first signs of aging and possibly before retirement age with physiological reserves that are gradually depleted. Frailty is multifactorial. It is situated between the "robust-vigorous" and "poly-pathological-dependent" stages of aging. This state remains dynamic and above all reversible through screening and awareness of the individual's health determinants as well as motivation to change. The Longevity Pathway was designed to meet several concrete objectives ranging from improving prevention to advancing research on the topic of longevity and aging well. This study aims to evaluate the effect of this personalized support on the quality of life of the consultants, but also on many health parameters, 12 months after the end of the proposed coaching.
Status | Completed |
Enrollment | 100 |
Est. completion date | December 21, 2023 |
Est. primary completion date | December 21, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Man or Woman; - Retired; - Having the desire to change his/her lifestyle; - Agreeing to follow the constraints generated by the study (presence during the coaching sessions and the final assessment). - Having signed the informed consent form; - Social insured; Exclusion Criteria: - Presenting a pathology requiring a complementary assessment and/or the implementation of a treatment that could prevent the realization of the coaching or that could modify its effect; - Subject participating in another clinical study or in period of exclusion from another study; - Subject deprived of liberty; - Subject under judicial protection measure; - Whose main investigator or a qualified co-investigator judges that the state of health or the concomitant treatments are not compatible with the good progress of the clinical study;. |
Country | Name | City | State |
---|---|---|---|
France | NutrInvest - Institut Pasteur de Lille | Lille | Nord |
Lead Sponsor | Collaborator |
---|---|
Institut Pasteur de Lille |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline on quality of life of retired people 12 months after the end of the coaching sessions. | Health quality will be evaluated thanks to a health quality questionnary validated by the World Health Organisation (WHO). | 1 year | |
Secondary | Change from baseline on food behaviors at 1 year after the coaching | Food behaviors will be measure with Balance and dietary diversity questionnaire proposed by the Institut Pasteur de Lille | 1 year | |
Secondary | Change from baseline on food frequency at 1 year after the coaching | Food frequency will be measure with 24-hour reminder of ingestas
- Visual analogue scales on changes in eating behavior. |
1 year | |
Secondary | Change from baseline on food behavior at 1 year after the coaching | Food behaviors will be measure with Visual analogue scales on changes in eating behavior from 10 (yes really a lot) to 0 (not at all) | 1 year | |
Secondary | Change from baseline on physical activity behaviors at 1 year after the coaching | Visual Analog Scales for Behavioral Change Related to Physical Activity raging from 10 (yes really a lot) to 0 (not at all) | 1 year | |
Secondary | Change from baseline on physical activity frequency at 1 year after the coaching | Marshall Questionnaire for Physical Activity frequency and two questions to evaluate the sedentarity livestyle level. | 1 year | |
Secondary | Change from baseline on endurance at 1 year after the coaching | The using test is :
• 6 minutes walk test (endurance) Measured in meters |
1 year | |
Secondary | Change from baseline on physical performances (lower limbs) at 1 year after the coaching | The using test is :
• Stand up chair test to calculate the number of raise on 30 seconds |
1 year | |
Secondary | Change from baseline on physical performances (upper limbs) at 1 year after the coaching | The using test is :
•Arm curl test to calculate the number of arm bend |
1 year | |
Secondary | Change from baseline on flexibility at 1 year after the coaching | The using test is :
•Flexible trunk and posterior chain of lower limbs Measured by index ranging from 5 (the palms of the hands touch the ground) to 1 (the fingertips reach the lower shins) |
1 year | |
Secondary | Change from baseline on static balance at 1 year after the coaching | The using test is :
Unipodal balance (static balance) Measured in seconds |
1 year | |
Secondary | Change from baseline on mobility at 1 year after the coaching | The using test is :
Get up and go test Measured by index ranging from 5 (the worst) to 1 (the best) |
1 year | |
Secondary | Change from baseline on speed at 1 year after the coaching | The using test is :
4 meters walking speed Measured in seconds |
1 year | |
Secondary | Change from baseline on dynamic balance at 1 year after the coaching | The using test is :
2 minutes on the spot knee climb This test explores the muscular strength of the lower limbs, dynamic balance and walking Measured in number of knee climb in 2 minutes |
1 year | |
Secondary | Change from baseline on cognitive performances at 1 year after the coaching | Cognitive performances will be measure with :
- Montreal cognitive assessment test (MOCA test) to evaluate mild cognitive dysfunction |
1 year | |
Secondary | Change from baseline on memory at 1 year after the coaching | It will be measure with :
- Working Memory Questionnaire |
1 year | |
Secondary | Change from baseline on sleep quality at 1 year after the coaching | It will be measure with :
- Insomnia Severity Index (ISI) to assess sleep quality |
1 year | |
Secondary | Change from baseline on stress management at 1 year after the coaching | It will be measure with :
- Cohen's Questionnaire |
1 year | |
Secondary | Change from baseline on anxiety at 1 year after the coaching | It will be measure with :
- Hospital Anxiety And Depression Queqtionnaire (HAD questionnaire to assess anxiety and depression) |
1 year | |
Secondary | Glucose metabolism | Blood samples will be collected to analyse fasting blood glucose | 1 year | |
Secondary | Lipids metabolism | Blood samples will be collected to analyse: total cholesterol, HDL, LDL, TG | 1 year | |
Secondary | Anthropometric parameters (Body Masse Index) | Weight in kilograms and height in meters will be combined to report BMI in kg/m^2 | 1 year | |
Secondary | Anthropometric parameters (waist circumference) | - Waist circumference in centimeters | 1 year | |
Secondary | Body composition | Measurement of body fat by DEXA (Dual X Ray Absorptiometry) for half of the total population :
Body fat in grams Lean mass in grams Total mass in grams Visceral fat mass in grams subcutaneous fat mass in grams Bone mineral content in grams |
1 year | |
Secondary | Body composition | Measurement of lean mass by DEXA (Dual X Ray Absorptiometry) for half of the total population :
Body fat in percentage Lean mass in percentage Visceral fat mass in percentage subcutaneous fat mass in percentage |
1 year | |
Secondary | Body composition (bone mineral density) | Measurement by DEXA (Dual X Ray Absorptiometry) for half of the total population :
- Bone mineral density in grams/cm² |
1 year | |
Secondary | Systolic and diastolic blood pressure | Systolic and diastolic blood pressure to calculate blood pressure | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |